220 related articles for article (PubMed ID: 28968173)
1. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group.
Uldrick TS; Ison G; Rudek MA; Noy A; Schwartz K; Bruinooge S; Schenkel C; Miller B; Dunleavy K; Wang J; Zeldis J; Little RF
J Clin Oncol; 2017 Nov; 35(33):3774-3780. PubMed ID: 28968173
[TBL] [Abstract][Full Text] [Related]
2. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Brain Metastases Working Group.
Lin NU; Prowell T; Tan AR; Kozak M; Rosen O; Amiri-Kordestani L; White J; Sul J; Perkins L; Beal K; Gaynor R; Kim ES
J Clin Oncol; 2017 Nov; 35(33):3760-3773. PubMed ID: 28968165
[TBL] [Abstract][Full Text] [Related]
3. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Organ Dysfunction, Prior or Concurrent Malignancy, and Comorbidities Working Group.
Lichtman SM; Harvey RD; Damiette Smit MA; Rahman A; Thompson MA; Roach N; Schenkel C; Bruinooge SS; Cortazar P; Walker D; Fehrenbacher L
J Clin Oncol; 2017 Nov; 35(33):3753-3759. PubMed ID: 28968172
[TBL] [Abstract][Full Text] [Related]
4. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group.
Magnuson A; Bruinooge SS; Singh H; Wilner KD; Jalal S; Lichtman SM; Kluetz PG; Lyman GH; Klepin HD; Fleury ME; Hirsch B; Melemed A; Arnaldez FI; Basu Roy U; Schenkel C; Sherwood S; Garrett-Mayer E
Clin Cancer Res; 2021 May; 27(9):2424-2429. PubMed ID: 33563633
[TBL] [Abstract][Full Text] [Related]
5. Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.
Kim ES; Bruinooge SS; Roberts S; Ison G; Lin NU; Gore L; Uldrick TS; Lichtman SM; Roach N; Beaver JA; Sridhara R; Hesketh PJ; Denicoff AM; Garrett-Mayer E; Rubin E; Multani P; Prowell TM; Schenkel C; Kozak M; Allen J; Sigal E; Schilsky RL
J Clin Oncol; 2017 Nov; 35(33):3737-3744. PubMed ID: 28968170
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working Group.
Gore L; Ivy SP; Balis FM; Rubin E; Thornton K; Donoghue M; Roberts S; Bruinooge S; Ersek J; Goodman N; Schenkel C; Reaman G
J Clin Oncol; 2017 Nov; 35(33):3781-3787. PubMed ID: 28968169
[TBL] [Abstract][Full Text] [Related]
8. Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement.
Kim ES; Uldrick TS; Schenkel C; Bruinooge SS; Harvey RD; Magnuson A; Spira A; Wade JL; Stewart MD; Vega DM; Beaver JA; Denicoff AM; Ison G; Ivy SP; George S; Perez RP; Spears PA; Tap WD; Schilsky RL
Clin Cancer Res; 2021 May; 27(9):2394-2399. PubMed ID: 33563632
[TBL] [Abstract][Full Text] [Related]
9. A New Approach to Simplifying and Harmonizing Cancer Clinical Trials-Standardizing Eligibility Criteria.
Gerber DE; Singh H; Larkins E; Ferris A; Forde PM; Selig W; Basu Roy U
JAMA Oncol; 2022 Sep; 8(9):1333-1339. PubMed ID: 35925576
[TBL] [Abstract][Full Text] [Related]
10. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group.
Spira AI; Stewart MD; Jones S; Chang E; Fielding A; Richie N; Wood LS; Thompson MA; Jones L; Nair A; Mahal BA; Gerber DE
Clin Cancer Res; 2021 May; 27(9):2416-2423. PubMed ID: 33563636
[TBL] [Abstract][Full Text] [Related]
11. Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research.
Ebrahimi H; Castro DV; Feng MI; Prajapati SR; Lee KO; Chan EH; Paul T; Sehgal I; Patel J; Li X; Zengin ZB; Meza L; Mercier BD; Hsu J; Govindarajan A; Chawla N; Dizman N; Bergerot CD; Rock A; Liu S; Tripathi A; Dorff T; Pal SK; Chehrazi-Raffle A
Clin Genitourin Cancer; 2023 Dec; 21(6):e467-e473. PubMed ID: 37301665
[TBL] [Abstract][Full Text] [Related]
12. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Washout Period and Concomitant Medication Work Group.
Harvey RD; Mileham KF; Bhatnagar V; Brewer JR; Rahman A; Moravek C; Kennedy AS; Ness EA; Dees EC; Ivy SP; Ebbinghaus SW; Schenkel C; Uldrick TS
Clin Cancer Res; 2021 May; 27(9):2400-2407. PubMed ID: 33563635
[TBL] [Abstract][Full Text] [Related]
13. Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.
Garcia S; Bisen A; Yan J; Xie XJ; Ramalingam S; Schiller JH; Johnson DH; Gerber DE
J Thorac Oncol; 2017 Oct; 12(10):1489-1495. PubMed ID: 28802905
[TBL] [Abstract][Full Text] [Related]
14. Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group.
Forde PM; Bonomi P; Shaw A; Blumenthal GM; Ferris A; Patel C; Melemed A; Basu Roy U; Ramamoorthy A; Liu Q; Burns T; Gainor JF; Lovly C; Piotrowska Z; Lehman J; Selig W
Clin Lung Cancer; 2020 Jul; 21(4):295-307. PubMed ID: 32201247
[TBL] [Abstract][Full Text] [Related]
15. Implementing Modernized Eligibility Criteria in US National Cancer Institute Clinical Trials.
Denicoff AM; Ivy SP; Tamashiro TT; Zhao J; Worthington KH; Mooney MM; Little RF
J Natl Cancer Inst; 2022 Nov; 114(11):1437-1440. PubMed ID: 36047830
[TBL] [Abstract][Full Text] [Related]
16. Re-Evaluating Eligibility Criteria for Oncology Clinical Trials: Analysis of Investigational New Drug Applications in 2015.
Jin S; Pazdur R; Sridhara R
J Clin Oncol; 2017 Nov; 35(33):3745-3752. PubMed ID: 28968168
[TBL] [Abstract][Full Text] [Related]
17. Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.
Unger JM; Hershman DL; Fleury ME; Vaidya R
JAMA Oncol; 2019 Mar; 5(3):326-333. PubMed ID: 30629092
[TBL] [Abstract][Full Text] [Related]
18. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Prior Therapies Work Group.
Osarogiagbon RU; Vega DM; Fashoyin-Aje L; Wedam S; Ison G; Atienza S; De Porre P; Biswas T; Holloway JN; Hong DS; Wempe MM; Schilsky RL; Kim ES; Wade JL
Clin Cancer Res; 2021 May; 27(9):2408-2415. PubMed ID: 33563637
[TBL] [Abstract][Full Text] [Related]
19. Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy.
Castro DV; Prajapati SR; Feng MI; Chan EH; Lee KO; Paul T; Sehgal I; Patel J; Li X; Zengin ZB; Ebrahimi H; Govindarajan A; Meza L; Mercier BD; Chawla NS; Dizman N; Philip EJ; Hsu J; Bergerot CD; Chehrazi-Raffle A; Rock A; Liu S; Tripathi A; Dorff TB; Pal SK
BJU Int; 2024 Mar; 133(3):297-304. PubMed ID: 37548533
[TBL] [Abstract][Full Text] [Related]
20. Automated classification of eligibility criteria in clinical trials to facilitate patient-trial matching for specific patient populations.
Zhang K; Demner-Fushman D
J Am Med Inform Assoc; 2017 Jul; 24(4):781-787. PubMed ID: 28339690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
